TT Index

The Therapeutics Today newsletters that were published more that 2 years ago are now archived.

Recent Therapeutics Today newsletters can be found either below or they are available on request to nmic@stjames.ie

2025

October

  • Guidance and Advice
  • Regular features
  • Signposting

September

  • Guidance and Advice
  • Regular features
  • Signposting

August

  • Guidance and Advice
  • Regular features
  • Signposting

June/July

  • Guidance and Advice
  • Regular features
  • Signposting

May

  • Guidance and advice
  • Regular features
  • Signposting

April

  • Guidance and advice
  • Regular features
  • Signposting

March

  • Guidance and advice
  • Regular features
  • Signposting

February

  • Guidance and advice
  • Regular features
  • Signposting

January

  • Guidance and advice
  • Regular features
  • Signposting

2024

December

  • Recent NMIC Bulletin
  • Guidance and Advice
  • Regular features
  • Signposting

November

  • Recent NMIC Bulletin
  • Guidance and Advice
  • Regular features
  • Signposting

October

  • Recent NMIC Bulletin
  • Guidance and Advice
  • Regular features
  • Signposting

September

  • Recent NMIC Bulletin
  • Guidance and Advice
  • Regular features
  • Signposting

August

  • Recent NMIC Bulletins
  • Guidance and Advice
  • Regular features
  • Signposting

July

  • Guidance and Advice
  • HSE Antibiotic Prescribing
  • Medication Safety Minutes
  • Communicable Diseases
  • Signposting

June

  • Guidance and Advice
  • Antibiotic Prescribing
  • Medication Safety
  • Regulatory Information
  • Communicable Diseases
  • SignPosting

May

  • Risk of adverse events following the initiation of antihypertensives in older people with complex health needs
  • New NMIC learning module on HSeLanD
  • Age-related risk of serious fall events and opioid Analgesic Use
  • Use of progestogens and the risk of intracranial meningioma

April

  • Practical prescribing: proton pump inhibitors (PPIs)
  • Results of NMIC survey 2024
  • Prevalence of potentially medications among newly treated patients with type 2 diabetes mellitus (T2DM)
  • Learning to swallow pills?
  • Health Products Regulatory Authority (HPRA) update

March

  • Practical prescribing - thiazides diuretics
  • Correct storage of biological disease-modifying  anti-rheumatic drugs at home
  • Drug-induced dermatomyositis
  • Potentially inappropriate prescribing and potential prescribing omissions and their association with adverse drug reaction-related hospital admission

February

  • Gabapentinoids in Ireland 2010 to 2020
  • Medicine shortages
  • NMIC publications survey 2024
  • Crushed tablet administration for patients with dysphagia or enteral feeding

January

  • Help shape our publications, your opinion counts – please take the NMIC Survey 2024
  • Drug-drug interactions and risk of adverse drug reaction-related hospital admissions in the older population
  • Emollients – comparison of lotions, creams, gels and ointment for childhood eczema
  • Safety outcomes when switching between biosimilar and reference biological medicines

2023

  • December
    • Sharing prescription medications
    • "Weekend warrior” physical activity & incident cardiovascular disease
    • Breastfeeding & the incidence of infant illness in Ireland
    • Primary prevention of CVD of Mediterranean diet in women
  • November
    • Risk of Gastrointestinal Adverse Events Associated with GLP-1 Receptor Agonists for Weight Loss
    • Paediatric ADHD medication errors reported to US poison Centres
    • Managing drugs with anticholinergic activity

  • October

    • Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs.
    • Prevalence and predictors of primary non-adherence in primary care
    • Aspirin for secondary prevention of cardiovascular disease

  • September

    • Folic acid supplementation to prevent neural tube defects
    • Association between daily step count and all-cause and cardiovascular mortality
    • Cardiac and renal effects of sodium-glucose co-transporter 2 (SGLT2)
  • August
    • Electrolyte disturbances due to proton pump inhibitors (PPIs)
    • Vaccine hesitancy
    • Familial hypercholesterolaemia (FH)
  • July
    • COPD exacerbations and pneumonia hospitalisations among new users of combination maintenance inhalers.
    • Health Products Regulatory Authority updates
    • Polypharmacy and cumulative anticholinergic burden in older adults hospitalised with a fall
    • Low-dose aspirin and risk of serious falls and fractures in healthy older people
  • June
    • Bipolar disorder – monitoring drug interventions
    • Trends in severe outcomes of adults and patients hospitalised with COVID -19
    • Women’s pre-conception health in England
  • May
    • Medication work among nonagenarians
    • Use of pharmacy services in community-dwelling middle-age and older adults.
    • NMIC useful medicines information resources webpage
    • Oral anticoagulant safety audit
    • Prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN).
  • April
    • Breast cancer risk and contraception
    • NMIC CPD module on HSeLanD!
    • Prevention of hospital admissions for adverse drug reactions
    • Withdrawing from SSRI antidepressants
  • March
    • BRAINS & AIMS
    • Further NMIC learning module on HSeLanD!
    • Reduce unnecessary use of proton pump inhibitors (PPIs)
    • Teachable moment – Paxlovid   avoiding drug-drug interactions
    • Guideline updates
  • February
    • Metabolic adverse events associated with systemic corticosteroid therapy
    • Prevalence of drug-drug interactions in older adults in the community
    • Values and preferences of patients and caregivers regarding eczema treatment
    • Online eczema interventions to support self-care for children and young people
    • Updated National Clinical Guidelines in Obstetrics and Gynaecology
  • January
    • Adverse drug reactions in older people in the community in Ireland
    • Thinking of a New Year’s resolution
    • Gynaecomastia
    • Glucocorticoid induced adrenal insufficiency (GC-AL)
    • Regular Updates
    • New Feature

2022

  • December
    • Thank you very much!
    • Morning versus evening antihypertensive medicine
    • Health Products Authority (HPRA) Update
    • Switching from a metered dose inhaler to a dry powder inhaler – effects on climate emissions and asthma control
    • Effectiveness of physical activity interventions delivered or prompted by healthcare professionals in primary care
    • NMIC Therapeutics Today 2022
  • November
    • The revised isotretinoin pregnancy prevention programme: awareness, knowledge & implementation in practice of healthcare professionals.
    • Risk of co-prescribing non-steroidal anti-inflammatory drugs and oral anticoagulants.
    • Medicines Management Programme updates.
    • Effectiveness of preconception care interventions in primary care.
    • Paxlovid: update on prescribing and access
  • October
    • ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.
    • HSE-Medicines Management Programme Update
    • Trends in direct oral anticoagulant prescribing in primary care in England
    • Gastrointestinal bleeding risk after concomitant treatment with non-vitamin K oral anticoagulants and oral glucocorticoids.
  • September
    • Obesity and oral emergency contraception
    • Recent journal Articles on pregnancy
    • Prescribing trends of antihypertensive medicines in the UK over 31 years
    • Health Products Regulatory Authority updates
    • HSeLanD Learning Module
  • August
    • Adverse drug reactions, multimorbidity and polypharmacy
    • Information resources for Ukrainian medicines
    • NMIC useful information resources webpage update
    • Medication Safety Minutes
    • Guideline update
  • July Supplement
    • Paxlovid : Update on prescribing and access
    • Key safety Points
    • Eligibility and prescribing considerations
    • Drug-drug interactions
    • Supply
  • July
    • Opioids versus non-opioids following surgical discharge
    • Further NMIC learning module on HSeLanD
    • Management of Gout
    • Guidance documents update
  • June
    • Serotonin Syndrome
    • Intramuscular injections in patients taking anticoagulant
    • Guideline updates
    • Drug reaction with eosinophilia and systemic symptoms (DRESS)
    • Use of medications that may raise blood pressure
  • May
    • Long-term nitrofurantoin therapy
    • Health Products Regulatory Authority updates
    • Guideline updates
    • Montelukast and neuropsychiatric reactions
    • Dose of paracetamol and low body weight
    • Factors to consider when using medicines following bariatric surgery
  • April
    • Sodium valproate (Epilim) utilisations trends in Ireland
    • Emollients and risk of burns
    • Non- vitamin K antagonist oral anticoagulants (NOACs) and pharmacokinetic drug interactions
    • Examples of medicines that should be prescribed by brand name
    • Guideline updates
    • NMIC CPD modules on contraception
    • Ukrainian Medicines Information Resources
  • March
    • Paxlovid and risk of drug interactions
    • Ireland’s second One Health National Action Plan (iNAP2) on Antimicrobial Resistance 2021-2025
    • Regular Updates
    • Measles
  • February
    • Overactive bladder (OAB) in women
    • Regular updates
    • Patient adherence, satisfaction and knowledge of direct oral anticoagulants (DOACs)
    • Impact of Gp-delivered medication review of older patients with multimorbidity and polypharmacy
  • January
    • Associations of Statins adherence and lipid targets with adverse outcomes in patients following myocardial infarction
    • Fatal adverse drug reactions
    • Childhood constipation